Solstein Capital’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.9K | Hold |
500
| – | – | ﹤0.01% | 346 |
|
|
2025
Q1 | $8.91K | Hold |
500
| – | – | 0.01% | 244 |
|
|
2024
Q4 | $14.9K | Hold |
500
| – | – | 0.01% | 221 |
|
|
2024
Q3 | $7.82K | Hold |
500
| – | – | ﹤0.01% | 255 |
|
|
2024
Q2 | $8.57K | Hold |
500
| – | – | 0.01% | 245 |
|
|
2024
Q1 | $7.82K | Hold |
500
| – | – | 0.01% | 246 |
|
|
2023
Q4 | $7.47K | Hold |
500
| – | – | 0.01% | 246 |
|
|
2023
Q3 | $8.08K | Hold |
500
| – | – | 0.01% | 241 |
|
|
2023
Q2 | $20.8K | Hold |
500
| – | – | 0.02% | 180 |
|
|
2023
Q1 | $30.1K | Hold |
500
| – | – | 0.03% | 158 |
|
|
2022
Q4 | $36.7K | Hold |
500
| – | – | 0.03% | 162 |
|
|
2022
Q3 | $38K | Hold |
500
| – | – | 0.03% | 171 |
|
|
2022
Q2 | $35K | Hold |
500
| – | – | 0.03% | 196 |
|
|
2022
Q1 | $41K | Hold |
500
| – | – | 0.03% | 210 |
|
|
2021
Q4 | $38K | Sell |
500
-500
| -50% | -$38K | 0.02% | 232 |
|
|
2021
Q3 | $116K | Hold |
1,000
| – | – | 0.07% | 164 |
|
|
2021
Q2 | $222K | Buy |
+1,000
| New | +$222K | 0.27% | 89 |
|